FOXO3 and ischemia: These findings implied that GP17 activated the expression of the downstream protein SIRT1/2 through NAMPT, upregulated FOXO3A and MnSOD expression, inhibited mitochondrial oxidative damage, improved energy metabolism, and thereby inhibited neurological damage caused by ischemia.